This exciting seminar series, organised by the HEAL-COVID trial team, is a fantastic resource to hear from leading clinicians and researchers working at the forefront of COVID-19 therapeutics and management.

Find details of the upcoming speakers below. The series is open to all, and you can register your interest at the links below.

Genetic implications for targeted therapeutics in COVID

Prof. Kenneth Baillie, University of Edinburgh

Tuesday 8 March, 2022 at 16:00h

Registration link:

Fibrosis and COVID-19

Prof. Gisli Jenkins, Imperial College London

Tuesday 5 April, 2022 at 16:00h

Registration link: